No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 9 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Zhongchao Inc. (ZCMD) stock was $1.78 as of Oct 6, 2026, 3:00 PM EDT, down 6.76% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -99.9% · 3-year avg -95.1%/yr · 5-year avg -84.8%/yr
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China.
Medical - Healthcare Information Services · Shanghai, SH
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$5.77M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ZCMD | $30,924 | $1.78 | -6.76% | -99.89% | -84.76% | N/A | N/A |
| 2MNDR | $30,263 | $1.23 | -3.95% | -99.03% | N/A | N/A | vs ZCMD |
| 3NIVF | $5,976 | $0.09 | -14.00% | -99.99% | N/A | N/A | vs ZCMD |
| 4AKAN | $63,276 | $1.96 | +2.36% | -96.82% | N/A | N/A | vs ZCMD |
| 5PRFX | $70,876 | $0.88 | -0.47% | -87.06% | -74.50% | N/A | vs ZCMD |
| 6PBM | $95,097 | $5.00 | -1.57% | -73.54% | N/A | N/A | vs ZCMD |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$1.78
High
N/A
